Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Amgen Net Income 2006-2020 | AMGN

Amgen annual/quarterly net income history and growth rate from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Amgen net income for the quarter ending June 30, 2020 was $1.803B, a 17.26% decline year-over-year.
  • Amgen net income for the twelve months ending June 30, 2020 was $7.299B, a 8.28% decline year-over-year.
  • Amgen annual net income for 2019 was $7.842B, a 6.58% decline from 2018.
  • Amgen annual net income for 2018 was $8.394B, a 324.15% increase from 2017.
  • Amgen annual net income for 2017 was $1.979B, a 74.37% decline from 2016.
  
Amgen Annual Net Income
(Millions of US $)
2019 $7,842
2018 $8,394
2017 $1,979
2016 $7,722
2015 $6,939
2014 $5,158
2013 $5,081
2012 $4,345
2011 $3,683
2010 $4,627
2009 $4,605
2008 $4,052
2007 $3,078
2006 $2,950
2005 $3,674
Amgen Quarterly Net Income
(Millions of US $)
2020-06-30 $1,803
2020-03-31 $1,825
2019-12-31 $1,703
2019-09-30 $1,968
2019-06-30 $2,179
2019-03-31 $1,992
2018-12-31 $1,928
2018-09-30 $1,859
2018-06-30 $2,296
2018-03-31 $2,311
2017-12-31 $-4,264
2017-09-30 $2,021
2017-06-30 $2,151
2017-03-31 $2,071
2016-12-31 $1,935
2016-09-30 $2,017
2016-06-30 $1,870
2016-03-31 $1,900
2015-12-31 $1,800
2015-09-30 $1,863
2015-06-30 $1,653
2015-03-31 $1,623
2014-12-31 $1,294
2014-09-30 $1,244
2014-06-30 $1,547
2014-03-31 $1,073
2013-12-31 $1,021
2013-09-30 $1,368
2013-06-30 $1,258
2013-03-31 $1,434
2012-12-31 $788
2012-09-30 $1,107
2012-06-30 $1,266
2012-03-31 $1,184
2011-12-31 $934
2011-09-30 $454
2011-06-30 $1,170
2011-03-31 $1,125
2010-12-31 $1,022
2010-09-30 $1,236
2010-06-30 $1,202
2010-03-31 $1,167
2009-12-31 $931
2009-09-30 $1,386
2009-06-30 $1,269
2009-03-31 $1,019
2008-12-31 $925
2008-09-30 $1,121
2008-06-30 $906
2008-03-31 $1,100
2007-12-31 $747
2007-09-30 $201
2007-06-30 $1,019
2007-03-31 $1,111
2006-12-31 $833
2006-09-30 $1,102
2006-06-30 $14
2006-03-31 $1,001
2005-12-31 $824
2005-09-30 $967
2005-06-30 $1,029
2005-03-31 $854
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $144.877B $23.362B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.725B 11.17
CSL (CSLLY) Australia $90.574B 0.00
Gilead Sciences (GILD) United States $89.976B 12.95
Vertex Pharmaceuticals (VRTX) United States $72.806B 40.63
Regeneron Pharmaceuticals (REGN) United States $70.981B 27.36
Illumina (ILMN) United States $58.485B 60.10
Biogen (BIIB) United States $44.036B 7.54
Seattle Genetics (SGEN) United States $29.412B 0.00
Moderna (MRNA) United States $28.948B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.547B 0.00
Genmab (GMAB) Denmark $23.368B 19.23
Alexion Pharmaceuticals (ALXN) United States $22.980B 9.58
Genmab (GNMSF) Denmark $22.277B 66.14
Incyte (INCY) United States $22.126B 0.00
BioMarin Pharmaceutical (BMRN) United States $22.069B 200.07
BeiGene (BGNE) Cayman Islands $19.808B 0.00
BioNTech SE (BNTX) Germany $19.339B 0.00
Alnylam Pharmaceuticals (ALNY) United States $17.569B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.496B 70.16
Exact Sciences (EXAS) United States $14.278B 0.00
Galapagos (GLPG) Belgium $12.647B 37.20
Sarepta Therapeutics (SRPT) United States $12.340B 0.00
Horizon Therapeutics Public (HZNP) Ireland $12.032B 29.61
ARGENX SE-ADR (ARGX) Netherlands $11.190B 0.00
QIAGEN (QGEN) Netherlands $11.144B 32.40
Bio-Techne Corp (TECH) United States $10.659B 70.42
Immunomedics (IMMU) United States $10.254B 0.00
Novavax (NVAX) United States $9.034B 0.00
Repligen (RGEN) United States $8.310B 131.89
Guardant Health (GH) United States $8.136B 0.00
Ascendis Pharma (ASND) Denmark $7.614B 0.00
Exelixis (EXEL) United States $7.265B 25.47
ACADIA Pharmaceuticals (ACAD) United States $6.744B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.600B 16.42
CRISPR Therapeutics AG (CRSP) Switzerland $6.491B 201.09
Emergent Biosolutions (EBS) United States $6.245B 24.74
Vir Biotechnology (VIR) United States $5.839B 0.00
Acceleron Pharma (XLRN) United States $5.668B 0.00
Mirati Therapeutics (MRTX) United States $5.546B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.062B 0.00
Adaptive Biotechnologies (ADPT) United States $5.056B 0.00
Reata Pharmaceuticals (RETA) United States $4.962B 0.00
Zai Lab (ZLAB) China $4.663B 0.00
MorphoSys AG (MOR) Germany $4.534B 35.16
MyoKardia (MYOK) United States $4.498B 0.00
Global Blood Therapeutics (GBT) United States $4.295B 0.00
NeoGenomics (NEO) United States $4.263B 1286.67
China Biologic Products (CBPO) China $4.196B 23.33
Blueprint Medicines (BPMC) United States $4.154B 0.00
Halozyme Therapeutics (HALO) United States $3.850B 0.00
Amicus Therapeutics (FOLD) United States $3.847B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.808B 0.00
Bluebird Bio (BLUE) United States $3.494B 0.00
Inovio Pharmaceuticals (INO) United States $3.271B 0.00
Arena Pharmaceuticals (ARNA) United States $3.189B 0.00
Alkermes (ALKS) Ireland $2.971B 62.27
Principia Biopharma (PRNB) United States $2.925B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.763B 0.00
Insmed (INSM) United States $2.743B 0.00
Amarin (AMRN) Ireland $2.610B 0.00
Fate Therapeutics (FATE) United States $2.580B 0.00
Denali Therapeutics (DNLI) United States $2.563B 0.00
Twist Bioscience (TWST) United States $2.417B 0.00
Sorrento Therapeutics (SRNE) United States $2.049B 0.00
PHARMA MAR SA (PHMMF) Spain $1.922B 0.00
Ligand Pharmaceuticals (LGND) United States $1.911B 64.72
UniQure (QURE) Netherlands $1.893B 0.00
Viela Bio (VIE) United States $1.879B 0.00
Editas Medicine (EDIT) United States $1.744B 0.00
I-Mab (IMAB) China $1.735B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.693B 0.00
Mesoblast (MESO) Australia $1.678B 0.00
Sangamo Therapeutics (SGMO) United States $1.626B 0.00
Eidos Therapeutics (EIDX) United States $1.579B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.556B 0.00
Zymeworks (ZYME) Canada $1.478B 0.00
Epizyme (EPZM) United States $1.452B 0.00
Adverum Biotechnologies (ADVM) United States $1.436B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.410B 0.00
Zealand Pharma (ZEAL) Denmark $1.405B 0.00
Revance Therapeutics (RVNC) United States $1.398B 0.00
Intra-Cellular Therapies (ITCI) United States $1.389B 0.00
Mersana Therapeutics (MRSN) United States $1.383B 0.00
Cytokineticsorporated (CYTK) United States $1.348B 0.00
Coherus BioSciences (CHRS) United States $1.293B 9.02
NGM Biopharmaceuticals (NGM) United States $1.287B 0.00
REGENXBIO (RGNX) United States $1.278B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Arvinas (ARVN) United States $1.264B 0.00
Alector (ALEC) United States $1.223B 0.00
NantKwest (NK) United States $1.186B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.177B 0.00
Alcobra (ARCT) United States $1.113B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.109B 0.00
Akcea Therapeutics (AKCA) United States $1.104B 0.00
Compugen (CGEN) Israel $1.082B 0.00
Retrophin (RTRX) United States $1.026B 0.00
VBI Vaccines (VBIV) United States $0.999B 0.00
Intellia Therapeutics (NTLA) United States $0.989B 0.00
Beam Therapeutics (BEAM) United States $0.978B 0.00
Arcus Biosciences (RCUS) United States $0.970B 0.00
Heska (HSKA) United States $0.951B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.932B 40.04
Myriad Genetics (MYGN) United States $0.928B 47.88
Athenex (ATNX) United States $0.915B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.840B 0.00
Dynavax Technologies (DVAX) United States $0.826B 0.00
Cara Therapeutics (CARA) United States $0.802B 0.00
Vericel (VCEL) United States $0.775B 143.25
Intrexon (PGEN) United States $0.768B 0.00
Cellectis S.A (CLLS) France $0.743B 0.00
Pharming Group (PHGUF) Netherlands $0.739B 16.86
Morphic Holding (MORF) United States $0.723B 0.00
Codexis (CDXS) United States $0.718B 0.00
Castle Biosciences (CSTL) United States $0.694B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.681B 0.00
Frequency Therapeutics (FREQ) United States $0.673B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
MiMedx (MDXG) United States $0.637B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.628B 0.00
Kadmon Holdings (KDMN) United States $0.627B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.577B 4.94
Cue Biopharma (CUE) United States $0.566B 0.00
Agenus (AGEN) United States $0.559B 0.00
IBio (IBIO) United States $0.535B 0.00
Athersys (ATHX) United States $0.529B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.527B 0.00
Prothena (PRTA) Ireland $0.509B 0.00
Anika Therapeutics (ANIK) United States $0.506B 22.16
Kala Pharmaceuticals (KALA) United States $0.506B 0.00
AnaptysBio (ANAB) United States $0.503B 0.00
Prometic Life Sciences (LMNL) Canada $0.503B 0.00
MeiraGTx Holdings (MGTX) United States $0.495B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.492B 0.00
Cel-Sci (CVM) United States $0.478B 0.00
AC Immune SA (ACIU) Switzerland $0.474B 0.00
Syros Pharmaceuticals (SYRS) United States $0.474B 0.00
Clovis Oncology (CLVS) United States $0.472B 0.00
UROGEN PHARMA (URGN) United States $0.465B 0.00
Protagonist Therapeutics (PTGX) United States $0.452B 0.00
DBV Technologies S.A (DBVT) France $0.450B 0.00
BioDelivery Sciences (BDSI) United States $0.446B 23.42
Puma Biotechnology (PBYI) United States $0.429B 0.00
Avid Bioservices (CDMO) United States $0.425B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.403B 0.00
Kamada (KMDA) Israel $0.402B 16.70
Merus (MRUS) Netherlands $0.400B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.395B 0.00
Albireo Pharma (ALBO) United States $0.393B 0.00
Scholar Rock Holding (SRRK) United States $0.381B 0.00
PDL BioPharma (PDLI) United States $0.379B 333.00
ANI Pharmaceuticals (ANIP) United States $0.368B 7.16
Geron (GERN) United States $0.360B 0.00
MannKind (MNKD) United States $0.347B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.341B 0.00
Precision BioSciences (DTIL) United States $0.341B 0.00
CytomX Therapeutics (CTMX) United States $0.338B 0.00
WAVE Life Sciences (WVE) Singapore $0.320B 0.00
ChromaDex (CDXC) United States $0.317B 0.00
Trevena (TRVN) United States $0.315B 0.00
Seres Therapeutics (MCRB) United States $0.312B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.310B 0.00
ADMA Biologics Inc (ADMA) United States $0.292B 0.00
OSMOTICA PHARM (OSMT) United States $0.292B 0.00
Affimed (AFMD) Germany $0.290B 0.00
Menlo Therapeutics (MNLO) United States $0.288B 0.00
Pluristem Therapeutics (PSTI) Israel $0.281B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.278B 0.00
Starpharma Holdings (SPHRY) Australia $0.270B 0.00
Cellular Biomedicine (CBMG) United States $0.269B 0.00
Arbutus Biopharma (ABUS) United States $0.264B 0.00
Northwest Biotherapeutics (NWBO) United States $0.264B 0.00
Spero Therapeutics (SPRO) United States $0.257B 0.00
NextCure (NXTC) United States $0.254B 0.00
Pfenex (PFNX) United States $0.252B 0.00
Celldex Therapeutics (CLDX) United States $0.250B 0.00
Dyadic (DYAI) United States $0.249B 0.00
Abeona Therapeutics (ABEO) United States $0.247B 0.00
Fortress Biotech (FBIO) United States $0.239B 0.00
Aduro Biotech (ADRO) United States $0.236B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.235B 0.00
Selecta Biosciences (SELB) United States $0.231B 0.00
Verastem (VSTM) United States $0.231B 0.00
Five Prime Therapeutics (FPRX) United States $0.222B 0.00
HOOKIPA Pharma (HOOK) United States $0.221B 0.00
IVERIC Bio (ISEE) United States $0.220B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 9.50
Exicure (XCUR) United States $0.201B 0.00
Sutro Biopharma (STRO) United States $0.196B 0.00
Strongbridge Biopharma (SBBP) United States $0.194B 0.00
GENFIT S.A (GNFT) France $0.192B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.190B 0.00
XOMA (XOMA) United States $0.190B 0.00
Theratechnologies (THTX) Canada $0.181B 0.00
Aptinyx (APTX) United States $0.180B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Aytu Bioscience (AYTU) United States $0.175B 0.00
Liquidia Technologies (LQDA) United States $0.165B 0.00
Cerecor (CERC) United States $0.162B 0.00
VTv Therapeutics (VTVT) United States $0.161B 0.00
Bellus Health (BLU) Canada $0.160B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.142B 0.00
Eton Pharmaceuticals (ETON) United States $0.141B 0.00
TELA Bio (TELA) United States $0.139B 0.00
Kindred Biosciences (KIN) United States $0.138B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
VolitionRX (VNRX) United States $0.136B 0.00
Celyad SA (CYAD) Belgium $0.136B 0.00
Palatin Technologies (PTN) United States $0.135B 3.47
Lineage Cell Therapeutics (LCTX) United States $0.127B 0.00
Oncobiologics (OTLK) United States $0.127B 0.00
Checkpoint Therapeutics (CKPT) United States $0.126B 0.00
Biofrontera AG (BFRA) Germany $0.126B 0.00
Gritstone Oncology (GRTS) United States $0.124B 0.00
PHASEBIO PHARMA (PHAS) United States $0.123B 0.00
Cocrystal Pharma (COCP) United States $0.123B 0.00
Orgenesis (ORGS) United States $0.119B 0.00
SESEN BIO, INC (SESN) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.116B 0.00
Enzo Biochem (ENZ) United States $0.115B 0.00
Lumos Pharma (LUMO) United States $0.114B 0.00
Cyclerion Therapeutics (CYCN) United States $0.114B 0.00
Cardiff Oncology (CRDF) United States $0.110B 0.00
CorMedix Inc (CRMD) United States $0.109B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.109B 0.00
Vaccinex (VCNX) United States $0.107B 0.00
AIT Therapeutics (XAIR) United States $0.106B 0.00
AquaBounty Technologies (AQB) United States $0.105B 0.00
ARAVIVE, INC (ARAV) United States $0.096B 0.00
Organovo Holdings (ONVO) United States $0.092B 0.00
Antibe Therapeutics (ATBPF) Canada $0.090B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.088B 0.00
DiaMedica Therapeutics (DMAC) United States $0.086B 0.00
Unum Therapeutics (UMRX) United States $0.085B 0.00
Emmaus Life Sciences (EMMA) United States $0.082B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.079B 0.00
Proteostasis Therapeutics (PTI) United States $0.078B 0.00
Ecology Coatings (ABVC) United States $0.076B 0.00
Stealth BioTherapeutics (MITO) United States $0.074B 0.00
Synlogic (SYBX) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.071B 0.00
Bionano Genomics (BNGO) United States $0.066B 0.00
AnPac Bio-Medical Science (ANPC) China $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Soligenix (SNGX) United States $0.063B 0.00
Signal Genetics (MGEN) United States $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.061B 0.00
Edesa Biotech (EDSA) Canada $0.061B 0.00
Happiness Biotech Group (HAPP) China $0.061B 0.00
IMMURON (IMRN) Australia $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.052B 0.00
CollPlant Holdings (CLGN) Israel $0.051B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.051B 0.00
Prima BioMed (IMMP) Australia $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.049B 0.00
Curis (CRIS) United States $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Spherix (AIKI) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Cesca Therapeutics (THMO) United States $0.035B 0.00
Genetic Technologies (GENE) Australia $0.035B 0.00
OvaScience (MLND) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
Forte Biosciences (FBRX) United States $0.032B 0.00
Acorda Therapeutics (ACOR) United States $0.031B 0.00
Evogene (EVGN) Israel $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.028B 0.00
Novogen (KZIA) Australia $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
BioPharmX (TMBR) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Prana Biotechnology (ATHE) Australia $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.017B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00